333 related articles for article (PubMed ID: 2369012)
1. [Congenital atrioventricular block and maternal autoimmune diseases].
Herreman G; Sauvaget F; Généreau T; Galezowski N
Ann Med Interne (Paris); 1990; 141(3):234-8. PubMed ID: 2369012
[TBL] [Abstract][Full Text] [Related]
2. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
Yang CH; Chen JY; Lee SC; Luo SF
J Microbiol Immunol Infect; 2005 Oct; 38(5):365-9. PubMed ID: 16211147
[TBL] [Abstract][Full Text] [Related]
3. [Fetal complete heart block with myocarditis and maternal SS-A-/AA-B/antibodies].
Lang B; Wilhelm C; Gildein P; Vaith P; Schillinger H; Peter HH
Schweiz Med Wochenschr; 1990 Nov; 120(46):1741-4. PubMed ID: 2251494
[TBL] [Abstract][Full Text] [Related]
4. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
5. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].
Zemlin M; Bauer K; Dörner T; Altinöz H; Versmold H
Z Geburtshilfe Neonatol; 2002; 206(1):22-5. PubMed ID: 11887252
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
[TBL] [Abstract][Full Text] [Related]
7. [Congenital complete atrioventricular block in neonatal lupus erythematosus].
Andriessen P; Tanke R; Fiselier T
Tijdschr Kindergeneeskd; 1993 Oct; 61(5):178-82. PubMed ID: 8266312
[TBL] [Abstract][Full Text] [Related]
8. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options.
Costedoat-Chalumeau N; Amoura Z; Villain E; Cohen L; Piette JC
Arthritis Res Ther; 2005; 7(2):69-73. PubMed ID: 15743492
[TBL] [Abstract][Full Text] [Related]
9. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
[TBL] [Abstract][Full Text] [Related]
10. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of mothers of children with complete congenital heart block.
Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody].
Miyakata S; Takeuchi K; Yamaji K; Kanai Y; Tsuda H; Takasaki Y
Ryumachi; 2001 Aug; 41(4):726-35. PubMed ID: 11577401
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal lupus syndrome: Literature review].
Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
[TBL] [Abstract][Full Text] [Related]
14. Neonatal lupus erythematosus with congenital heart block associated with maternal systemic lupus erythematosus.
Houssiau FA; Lebacq EG
Clin Rheumatol; 1986 Dec; 5(4):505-8. PubMed ID: 3816098
[TBL] [Abstract][Full Text] [Related]
15. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
16. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
Makino S; Yonemoto H; Itoh S; Takeda S
Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
[No Abstract] [Full Text] [Related]
17. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
[TBL] [Abstract][Full Text] [Related]
18. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
Clancy RM; Buyon JP
Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
[TBL] [Abstract][Full Text] [Related]
19. Congenital complete heart block and maternal connective tissue disease.
Jayaprasad N; Johnson F; Venugopal K
Int J Cardiol; 2006 Sep; 112(2):153-8. PubMed ID: 16815568
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
